These results indicated that miR-10a could reverse the inhibitory effects of TUSC7 in HCC cells and TUSC7 could suppress EMT through the TUSC7-miR-10a-EphA4 axis. This evidence concerns the gene TUSC7 and hepatocellular carcinoma.